{"id":"https://openalex.org/W4367603597","doi":"https://doi.org/10.1158/1557-3125.ras23-b009","title":"Abstract B009: TEAD inhibition overcomes YAP1/TAZ-driven resistance to RAS inhibitors in KRASG12C-mutant cancers","display_name":"Abstract B009: TEAD inhibition overcomes YAP1/TAZ-driven resistance to RAS inhibitors in KRASG12C-mutant cancers","publication_year":2023,"publication_date":"2023-05-01","ids":{"openalex":"https://openalex.org/W4367603597","doi":"https://doi.org/10.1158/1557-3125.ras23-b009"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3125.ras23-b009","doi":"https://doi.org/10.1158/1557-3125.ras23-b009","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1557-3125.ras23-b009","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004033177","display_name":"A. Cole Edwards","orcid":"https://orcid.org/0000-0001-9220-9642","observed_orcids":["https://orcid.org/0000-0001-9220-9642"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander C. Edwards","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC,","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005237041","display_name":"Clint A. Stalnecker","orcid":"https://orcid.org/0000-0002-0570-4416","observed_orcids":["https://orcid.org/0000-0002-0570-4416"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clint A. Stalnecker","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC,","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080851359","display_name":"Alexis Jean Morales","orcid":"https://orcid.org/0009-0002-3711-934X","observed_orcids":["https://orcid.org/0009-0002-3711-934X"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexis J. Morales","raw_affiliation_strings":["2University of Pennsylvania, Philadelphia, PA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Pennsylvania, Philadelphia, PA,","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074233996","display_name":"Khalilah E. Taylor","orcid":"https://orcid.org/0009-0003-2136-2713","observed_orcids":["https://orcid.org/0009-0003-2136-2713"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khalilah E. Taylor","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC,","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009869639","display_name":"Jill F. Hallin","orcid":"https://orcid.org/0000-0002-8443-7116","observed_orcids":["https://orcid.org/0000-0002-8443-7116"]},"institutions":[{"id":"https://openalex.org/I4210103611","display_name":"Mirati Therapeutics (United States)","ror":"https://ror.org/01by01460","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103611"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jill Hallin","raw_affiliation_strings":["3Mirati Therapeutics, San Diego, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Mirati Therapeutics, San Diego, CA,","institution_ids":["https://openalex.org/I4210103611"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042557251","display_name":"Peter Olson","orcid":"https://orcid.org/0009-0008-5164-8102","observed_orcids":["https://orcid.org/0009-0008-5164-8102"]},"institutions":[{"id":"https://openalex.org/I4210103611","display_name":"Mirati Therapeutics (United States)","ror":"https://ror.org/01by01460","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103611"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Olson","raw_affiliation_strings":["3Mirati Therapeutics, San Diego, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Mirati Therapeutics, San Diego, CA,","institution_ids":["https://openalex.org/I4210103611"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009698094","display_name":"Tracy Tzu-Ling Tang","orcid":"https://orcid.org/0000-0003-3425-4263","observed_orcids":["https://orcid.org/0000-0003-3425-4263"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tracy T. Tang","raw_affiliation_strings":["4Vivace Therapeutics, San Mateo, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Vivace Therapeutics, San Mateo, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085891569","display_name":"Lars D. Engstrom","orcid":"https://orcid.org/0000-0001-8196-9427","observed_orcids":["https://orcid.org/0000-0001-8196-9427"]},"institutions":[{"id":"https://openalex.org/I4210103611","display_name":"Mirati Therapeutics (United States)","ror":"https://ror.org/01by01460","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103611"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lars Engstrom","raw_affiliation_strings":["3Mirati Therapeutics, San Diego, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Mirati Therapeutics, San Diego, CA,","institution_ids":["https://openalex.org/I4210103611"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085037854","display_name":"Leonard E. Post","orcid":"https://orcid.org/0009-0007-5779-4146","observed_orcids":["https://orcid.org/0009-0007-5779-4146"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leonard Post","raw_affiliation_strings":["4Vivace Therapeutics, San Mateo, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Vivace Therapeutics, San Mateo, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074923974","display_name":"James G. Christensen","orcid":"https://orcid.org/0000-0003-1835-0335","observed_orcids":["https://orcid.org/0000-0003-1835-0335"]},"institutions":[{"id":"https://openalex.org/I4210103611","display_name":"Mirati Therapeutics (United States)","ror":"https://ror.org/01by01460","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103611"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James G. Christensen","raw_affiliation_strings":["3Mirati Therapeutics, San Diego, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Mirati Therapeutics, San Diego, CA,","institution_ids":["https://openalex.org/I4210103611"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005839868","display_name":"Adrienne D. Cox","orcid":"https://orcid.org/0000-0002-4901-2454","observed_orcids":["https://orcid.org/0000-0002-4901-2454"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adrienne D. Cox","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC,","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064063895","display_name":"Channing J. Der","orcid":"https://orcid.org/0000-0002-7751-2747","observed_orcids":["https://orcid.org/0000-0002-7751-2747"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Channing J. Der","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC,","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"5_Supplement","first_page":"B009","last_page":"B009"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12065","display_name":"Hippo pathway signaling and YAP/TAZ","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12065","display_name":"Hippo pathway signaling and YAP/TAZ","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kras-inhibitors","display_name":"KRAS inhibitors","score":0.6959999799728394},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8130000233650208},{"id":"https://openalex.org/keywords/yap","display_name":"YAP","score":0.8199999928474426},{"id":"https://openalex.org/keywords/taz","display_name":"TAZ","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tead","display_name":"TEAD","score":0.7670000195503235},{"id":"https://openalex.org/keywords/hippo-signaling-pathway","display_name":"Hippo signaling pathway","score":0.8629999756813049},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.8429999947547913},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9869999885559082},{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":1.0},{"id":"https://openalex.org/keywords/transcriptional-coactivator","display_name":"transcriptional coactivator","score":0.8180000185966492},{"id":"https://openalex.org/keywords/tead-inhibitors","display_name":"TEAD inhibitors","score":0.6980000138282776},{"id":"https://openalex.org/keywords/crispr-cas9-loss-of-function-screen","display_name":"CRISPR-Cas9 loss-of-function screen","score":0.7860000133514404}],"concepts":[{"id":"https://openalex.org/C2780219982","wikidata":"https://www.wikidata.org/wiki/Q17544238","display_name":"YAP1","level":4,"score":0.9220520853996277},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.89272141456604},{"id":"https://openalex.org/C172512520","wikidata":"https://www.wikidata.org/wiki/Q5768379","display_name":"Hippo signaling pathway","level":3,"score":0.8240585327148438},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7224501371383667},{"id":"https://openalex.org/C97037327","wikidata":"https://www.wikidata.org/wiki/Q5334291","display_name":"Ectopic expression","level":3,"score":0.6768439412117004},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6119433045387268},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.6033387780189514},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.5245530605316162},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.504848301410675},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.31233787536621094},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.30294764041900635},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2725188732147217},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.25607097148895264},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.23577138781547546},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.21484437584877014},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.19574162364006042}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3125.ras23-b009","doi":"https://doi.org/10.1158/1557-3125.ras23-b009","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1557-3125.ras23-b009","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8500000238418579,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6925243668","https://openalex.org/W4388464749","https://openalex.org/W4389792969","https://openalex.org/W4362668006","https://openalex.org/W4405616017","https://openalex.org/W7148725825","https://openalex.org/W4379468630","https://openalex.org/W4386883000","https://openalex.org/W4382240796","https://openalex.org/W4399504533"],"abstract_inverted_index":{"Abstract":[0],"Activated":[1],"mutants":[2,208],"of":[3,33,53,59,69,75,111,114,122,135,160,173,187,228,243,270,285,294,302,353],"KRAS":[4,26,62,288],"comprise":[5],"the":[6,34,60,71,92,115,136,168,241,292,299,354],"major":[7],"oncogenic":[8],"drivers":[9,121],"in":[10,22,73,101,176,210,347],"lung":[11],"(LAC),":[12],"colorectal":[13],"(CRC),":[14],"and":[15,42,128,142,170,180,197,234,247,290],"pancreatic":[16],"ductal":[17],"(PDAC)":[18],"adenocarcinoma.":[19],"Recent":[20],"success":[21],"covalently":[23],"targeting":[24,91],"one":[25],"mutant":[27,233,250],"(KRASG12C)":[28],"led":[29],"to":[30,46,97,152,166,201,214,217,253,287,297,344],"FDA":[31],"approval":[32],"first":[35,155],"anti-KRAS":[36],"therapy":[37],"(G12Ci).":[38],"However,":[39],"both":[40,226],"primary":[41],"treatment-induced":[43],"acquired":[44],"resistance":[45,83,124,151,216,286,343],"G12Ci":[47,123,174,190,218],"have":[48,56],"been":[49],"observed.":[50],"While":[51],"analyses":[52,257],"relapsed":[54,102],"patients":[55,76,103],"identified":[57,109],"reactivation":[58],"key":[61],"effector":[63],"signaling":[64,280],"network":[65],"as":[66,120,281],"a":[67,87,222,229,259,268,282],"driver":[68,284],"resistance,":[70],"mechanisms":[72],"~50%":[74],"are":[77],"not":[78],"known.":[79],"To":[80],"identify":[81],"potential":[82],"mechanisms,":[84],"we":[85,107],"applied":[86],"CRISPR-Cas9":[88],"loss-of-function":[89],"screen":[90],"druggable":[93],"genome.":[94],"In":[95,274],"addition":[96],"genes":[98],"discovered":[99],"recently":[100],"(e.g.,":[104],"PTEN,":[105],"NF1),":[106],"also":[108],"loss":[110],"multiple":[112],"components":[113],"Hippo":[116,147],"tumor":[117],"suppressor":[118],"pathway":[119],"(NF2,":[125],"LATS1/2,":[126],"TAOK1/2":[127],"STK3/4).":[129],"We":[130,154,204],"therefore":[131],"determined":[132,156,205],"if":[133],"activation":[134],"functionally":[137],"related":[138],"transcriptional":[139,256],"co-activators,":[140],"YAP1":[141],"TAZ,":[143],"normally":[144],"inhibited":[145],"by":[146,266],"signaling,":[148],"can":[149],"drive":[150,215],"G12Ci.":[153,254],"that":[157,206],"ectopic":[158],"expression":[159],"constitutively":[161],"activated":[162],"YAP1/TAZ":[163,188,192,207,244],"was":[164],"sufficient":[165],"impair":[167],"anti-proliferative":[169],"pro-apoptotic":[171],"effects":[172,242],"treatment":[175,235],"KRASG12C-mutant":[177,348],"LAC,":[178],"CRC,":[179],"PDAC":[181],"cell":[182],"lines.":[183],"Conversely,":[184],"genetic":[185,245],"suppression":[186,246],"enhanced":[189],"sensitivity.":[191],"requires":[193],"association":[194],"with":[195,236],"TEAD":[196,211,230,295,339],"other":[198],"transcription":[199],"factors":[200],"regulate":[202],"transcription.":[203,273],"deficient":[209],"binding":[212],"failed":[213],"treatment.":[219],"Further":[220],"supporting":[221],"role":[223],"for":[224],"TEAD,":[225],"overexpression":[227],"dominant":[231],"negative":[232],"pan-TEAD":[237],"pharmacological":[238],"inhibitors":[239,296,346],"phenocopied":[240],"sensitized":[248],"KRASG12C":[249,264],"cancer":[251],"cells":[252],"Finally,":[255],"support":[258,278,291],"model":[260],"where":[261],"YAP1/TAZ-TEAD":[262,279],"overcomes":[263,341],"addiction":[265],"restoring":[267],"subset":[269],"KRAS-dependent":[271],"gene":[272],"summary,":[275],"our":[276],"observations":[277],"novel":[283],"inhibition":[289,340],"use":[293],"enhance":[298],"anti-tumor":[300],"efficacy":[301],"KRAS-targeted":[303],"therapies.":[304],"Citation":[305],"Format:":[306],"Alexander":[307],"C.":[308],"Edwards,":[309],"Clint":[310],"A.":[311],"Stalnecker,":[312],"Alexis":[313],"J.":[314,337],"Morales,":[315],"Khalilah":[316],"E.":[317],"Taylor,":[318],"Jill":[319],"Hallin,":[320],"Peter":[321],"Olson,":[322],"Tracy":[323],"T.":[324],"Tang,":[325],"Lars":[326],"Engstrom,":[327],"Leonard":[328],"Post,":[329],"James":[330],"G.":[331],"Christensen,":[332],"Adrienne":[333],"D.":[334],"Cox,":[335],"Channing":[336],"Der.":[338],"YAP1/TAZ-driven":[342],"RAS":[345],"cancers":[349],"[abstract].":[350],"In:":[351],"Proceedings":[352],"AACR":[355],"Special":[356],"Conference:":[357],"Targeting":[358],"RAS;":[359],"2023":[360],"Mar":[361],"5-8;":[362],"Philadelphia,":[363],"PA.":[364],"Philadelphia":[365],"(PA):":[366],"AACR;":[367],"Mol":[368],"Cancer":[369],"Res":[370],"2023;21(5_Suppl):Abstract":[371],"nr":[372],"B009.":[373]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-05-02T00:00:00"}